AVITA Drug Patent Profile
✉ Email this page to a colleague
When do Avita patents expire, and when can generic versions of Avita launch?
Avita is a drug marketed by Mylan Pharms Inc and Norvium Bioscience and is included in two NDAs.
The generic ingredient in AVITA is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Avita
A generic version of AVITA was approved as tretinoin by PADAGIS US on December 24th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AVITA?
- What are the global sales for AVITA?
- What is Average Wholesale Price for AVITA?
Summary for AVITA
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 1,696 |
Drug Prices: | Drug price information for AVITA |
Drug Sales Revenues: | Drug sales revenues for AVITA |
What excipients (inactive ingredients) are in AVITA? | AVITA excipients list |
DailyMed Link: | AVITA at DailyMed |
US Patents and Regulatory Information for AVITA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Norvium Bioscience | AVITA | tretinoin | GEL;TOPICAL | 020400-001 | Jan 29, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AVITA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AVITA
See the table below for patents covering AVITA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ireland | 66710 | Compositions for enhancing the cutaneous penetration of pharmacologically active agents | ⤷ Sign Up |
Greece | 3015410 | ⤷ Sign Up | |
Spain | 2065912 | ⤷ Sign Up | |
Canada | 1331861 | METHODE ET COMPOSITIONS POUR AUGMENTER LA PENETRATION CUTANEE D'AGENTS PHARMACEUTIQUES ACTIFS (METHOD AND COMPOSITIONS FOR ENHANCING THE CUTANEOUS PENETRATION OF PHARMACOLOGICALLY ACTIVE AGENTS) | ⤷ Sign Up |
Germany | 3852437 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for AVITA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0617614 | 2001/009 | Ireland | ⤷ Sign Up | PRODUCT NAME: PANRETIN-ALITRETINOIN |
1304992 | 2013/044 | Ireland | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322 |
1304992 | 92401 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE |
1304992 | PA2013025,C1304992 | Lithuania | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323 |
0617614 | C300043 | Netherlands | ⤷ Sign Up | PRODUCT NAME: ALITRETINOIN; NAT. REGISTRATION NO/DATE: EU/1/00/149/001 20001011; FIRST REGISTRATION: EU/1/00/149/001 20001011 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |